Literature DB >> 22797929

Unexamined challenges to applying the treatment as prevention model among men who have sex with men in the United States: a community public health perspective.

Stephen J Fallon1, David W Forrest.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22797929     DOI: 10.1007/s10461-012-0258-2

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


× No keyword cloud information.
  5 in total

1.  Effects of messaging about multiple biomedical and behavioral HIV prevention methods on intentions to use among US MSM: results of an experimental messaging study.

Authors:  Brian Mustanski; Daniel T Ryan; Travis Sanchez; Craig Sineath; Kathryn Macapagal; Patrick S Sullivan
Journal:  AIDS Behav       Date:  2014-09

2.  Factors associated with recent HIV testing among younger gay and bisexual men in New Zealand, 2006-2011.

Authors:  Nathan J Lachowsky; Peter J W Saxton; Nigel P Dickson; Anthony J Hughes; Alastair J S Summerlee; Cate E Dewey
Journal:  BMC Public Health       Date:  2014-03-31       Impact factor: 3.295

Review 3.  Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?

Authors:  Myron S Cohen; M Kumi Smith; Kathryn E Muessig; Timothy B Hallett; Kimberly A Powers; Angela D Kashuba
Journal:  Lancet       Date:  2013-10-23       Impact factor: 79.321

4.  Integration of Social, Cultural, and Biomedical Strategies into an Existing Couple-Based Behavioral HIV/STI Prevention Intervention: Voices of Latino Male Couples.

Authors:  Omar Martinez; Elwin Wu; Ethan C Levine; Miguel Muñoz-Laboy; M Isabel Fernandez; Sarah Bauerle Bass; Eva M Moya; Timothy Frasca; Silvia Chavez-Baray; Larry D Icard; Hugo Ovejero; Alex Carballo-Diéguez; Scott D Rhodes
Journal:  PLoS One       Date:  2016-03-30       Impact factor: 3.240

5.  A meta-analysis of the efficacy of HAART on HIV transmission and its impact on sexual risk behaviours among men who have sex with men.

Authors:  Ying Jiang; Shu Su; Yan Borné
Journal:  Sci Rep       Date:  2020-01-23       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.